Media ReleasesAuscann Group Holdings

View All Auscann Group Holdings News


AusCann Announces Pharmaceutical Executive Joins Board

Thursday, 27 September 2018 – Leading medical cannabis company AusCann Group Holdings Limited (ASX:AC8) (AusCann or ‘the Company’) is pleased to advise that experienced pharmaceutical executive, Dr Paul MacLeman, has today joined the AusCann Board as an Executive Director.

Dr MacLeman has over 25 years’ board and executive experience across the life sciences, agricultural and not for profit sectors. This includes strategy formulation, capital raising, business development, technology commercialisation and sales & marketing. He has also launched a variety of products in Australia, the US and Asia, founded life sciences start-ups in the biologics area and worked in investment banking.


For further information please download PDF attached:
Download this document